Meeder Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Meeder Advisory Services's VRTX Position: Q2 2026 in Review
Meeder Advisory Services increased its Vertex Pharmaceuticals (VRTX) stake by 3.5% in Q2 2026, buying an estimated $96.6K and bringing the position to 6,415 shares worth $3.19M. The position accounts for 0.12% of the portfolio, ranked #118.
Meeder Advisory Services first reported a position in VRTX in Q4 2022 and has held it in 15 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Meeder Advisory Services held 6,415 shares of Vertex Pharmaceuticals worth $3.19M as of Q2 2026.
- Meeder Advisory Services bought 218 Vertex Pharmaceuticals shares in Q2 2026, an estimated $96.6K.
- Vertex Pharmaceuticals made up 0.12% of Meeder Advisory Services's portfolio in Q2 2026, its #118 holding.
- Meeder Advisory Services first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.